Viewing Study NCT04185051


Ignite Creation Date: 2025-12-24 @ 11:55 PM
Ignite Modification Date: 2026-01-03 @ 10:07 PM
Study NCT ID: NCT04185051
Status: COMPLETED
Last Update Posted: 2025-04-27
First Post: 2019-12-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Investigate the Effect of JNJ-67953964 on Gastric Mucosal Integrity in Healthy Male and Female Participants
Sponsor: Janssen Research & Development, LLC
Organization:

Study Overview

Official Title: A Double-blind, Randomized, Placebo Controlled, 4-week Study to Investigate the Effect of JNJ-67953964 on Gastric Mucosal Integrity in Healthy Male and Female Participants
Status: COMPLETED
Status Verified Date: 2025-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The main purpose of the study is to investigate the upper gastro-intestinal (GI)-related safety and tolerability in healthy participants by gastroscopy and gastric biopsies after treatment with 25 milligram (mg) JNJ-67953964 once daily (QD) over 4 weeks.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?:

Secondary ID Infos

Secondary ID Type Domain Link View
67953964EDI1001 OTHER Janssen Research & Development, LLC View
2019-001864-31 EUDRACT_NUMBER None View